Page last updated: 2024-10-28

lidocaine and Chagas Disease

lidocaine has been researched along with Chagas Disease in 2 studies

Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research Excerpts

ExcerptRelevanceReference
" We present a case secondary to Chagas disease that was responsive to lidocaine."4.12The imperfect storm: An uncommon presentation of Chagas disease. ( Johnson, MC; Wang, L, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Johnson, MC1
Wang, L1
Vichi, FL1
Campos, IB1
Romero, LC1
Tukiyama, A1

Other Studies

2 other studies available for lidocaine and Chagas Disease

ArticleYear
The imperfect storm: An uncommon presentation of Chagas disease.
    The American journal of emergency medicine, 2022, Volume: 61

    Topics: Arrhythmias, Cardiac; Chagas Disease; Defibrillators, Implantable; Humans; Lidocaine; Tachycardia, V

2022
[Effects of intravenous infusion of xylocaine on the extrasystole of chronic Chagasic cardiopathy].
    Revista paulista de medicina, 1972, Volume: 80, Issue:3

    Topics: Adult; Cardiac Complexes, Premature; Chagas Disease; Chronic Disease; Drug Evaluation; Female; Human

1972